Arbutus Biopharma Corporation
NasdaqGS:ABUS
$ 2.89
+ $0.08 (2.85%)
$ 2.89
+ $0.08 (2.85%)
End-of-day quote: 05/16/2024

ABUS: Global investment alternatives & competitors

Competitors

Ticker Price Forecast 1Y Forecast 2Y Market Cap Div Yld Growth Rate
ENXTPA:SAN
Sanofi
90.24 17.91% 36.66% 112,810.55 4.15% 8.19%
TSE:4568
Daiichi Sankyo Company
5482.00 0% 0% 10,508,692.98 1.09% 0%
NasdaqGS:MRNA
Moderna
132.68 -,110.73% -,107.41% 50,848.25 0% 0%
TSE:4502
Takeda Pharmaceutical Company
4138.00 0% 0% 6,492,248.28 4.74% 0%
NasdaqGS:BIIB
Biogen
230.04 -15.03% 0.05% 33,493.11 0% -10.89%
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
151.22 0% 0% 19,128.09 0% 0%
NasdaqGS:BMRN
BioMarin Pharmaceutical
76.97 154.97% 238.58% 14,615.05 0% 32.46%
NasdaqGS:SRPT
Sarepta Therapeutics
132.74 0% 0% 12,505.49 0% 0%
NasdaqGS:IONS
Ionis Pharmaceuticals
37.62 -,156.68% -,149.23% 5,756.54 0% 0%
NasdaqGS:DYN
Dyne Therapeutics
28.75 0% 0% 2,267.58 0% 0%
NasdaqGS:DCPH
Deciphera Pharmaceuticals
25.45 0% 0% 2,193.03 0% 0%
TSE:4516
Nippon Shinyaku
3675.00 0% 0% 261,328.78 3.32% 0%
NasdaqGM:WVE
Wave Life Sciences
5.90 0% 0% 688.23 0% 0%
NasdaqGS:STOK
Stoke Therapeutics
14.03 0% 0% 604.59 0% 0%
NasdaqGM:FULC
Fulcrum Therapeutics
7.80 0% 0% 456.83 0% 0%
ASX:PYC
PYC Therapeutics
0.10 0% 0% 294.9 0% 0%